← Open Payments lookup

ALLISON ZARTMAN: Open Payments

NPI 1598473464 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$774 in 48 payments from 13 companies in 2025. Trend: 2023 $476 · 2024 $344 · 2025 $774

Food & beverage: $774
CompanyPaymentsAmount
ABBVIE INC.12$142
Vanda Pharmaceuticals Inc.10$139
Neurocrine BioSciences, Inc.3$81
Tris Pharma Inc4$73
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$67
Corium, LLC4$54
Alkermes, Inc.3$51
Axsome Therapeutics, Inc.2$37
Takeda Pharmaceuticals U.S.A., Inc.2$36
Otsuka America Pharmaceutical, Inc.2$33

Products named: VRAYLAR, FANAPT, INGREZZA, CAPLYTA, Dyanavel XR, Azstarys, Auvelity, ARISTADA.

Industry payments across ID — which companies pay providers there.